Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $52,713 | 5 | 74.0% |
| Unspecified | $9,375 | 12 | 13.2% |
| Honoraria | $5,083 | 5 | 7.1% |
| Consulting Fee | $2,250 | 2 | 3.2% |
| Food and Beverage | $767.92 | 11 | 1.1% |
| Travel and Lodging | $680.74 | 4 | 1.0% |
| Education | $344.41 | 2 | 0.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $52,713 | 5 | $0 (2021) |
| Zimmer Biomet Holdings, Inc. | $9,564 | 13 | $0 (2022) |
| Myoscience Inc. | $6,583 | 7 | $0 (2018) |
| Smith+Nephew, Inc. | $1,430 | 11 | $0 (2024) |
| Pacira CryoTech Incorporated | $750.00 | 1 | $0 (2019) |
| BIOTISSUE HOLDINGS INC. | $110.71 | 1 | $0 (2024) |
| Vericel Corporation | $25.77 | 1 | $0 (2022) |
| Kerecis Limited | $21.25 | 1 | $0 (2023) |
| Arthrex, Inc. | $16.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $415.12 | 2 | Smith+Nephew, Inc. ($304.41) |
| 2023 | $21.25 | 1 | Kerecis Limited ($21.25) |
| 2022 | $175.24 | 2 | Zimmer Biomet Holdings, Inc. ($149.47) |
| 2021 | $10,366 | 3 | Pacira Pharmaceuticals Incorporated ($5,866) |
| 2020 | $10,966 | 2 | Pacira Pharmaceuticals Incorporated ($10,966) |
| 2019 | $41,006 | 9 | Pacira Pharmaceuticals Incorporated ($35,881) |
| 2018 | $6,264 | 18 | Myoscience Inc. ($5,083) |
| 2017 | $2,000 | 4 | Myoscience Inc. ($1,500) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | BIOTISSUE HOLDINGS INC. | CLARIX (Medical Supply) | Food and Beverage | In-kind items and services | $110.71 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 10/14/2024 | Smith+Nephew, Inc. | Q-FIX (Device), TWINFIX, HEALICOIL | Education | In-kind items and services | $304.41 | General |
| Category: Sports Med Shoulder | ||||||
| 04/26/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Wound Care | ||||||
| 04/07/2022 | Vericel Corporation | MACI (Biological) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Orthopedics | ||||||
| 01/27/2022 | Zimmer Biomet Holdings, Inc. | — | Food and Beverage | In-kind items and services | $149.47 | General |
| 07/07/2021 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $250.00 | Research |
| Study: nStride Saline Controlled Study • Category: Sports Medicine | ||||||
| 06/01/2021 | Pacira Pharmaceuticals Incorporated | Iovera System (Device) | Current or prospective ownership or investment interest | In-kind items and services | $5,866.29 | General |
| Category: Pain Management | ||||||
| 04/01/2021 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $4,250.00 | Research |
| Study: nStride Saline Controlled Study • Category: Sports Medicine | ||||||
| 05/01/2020 | Pacira Pharmaceuticals Incorporated | IOVERA SYSTEM (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $8,047.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/01/2020 | Pacira Pharmaceuticals Incorporated | IOVERA SYSTEM (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $2,917.62 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/20/2019 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $250.00 | Research |
| Study: nStride Saline Controlled Study • Category: Sports Medicine | ||||||
| 07/16/2019 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $1,500.00 | Research |
| Study: nStride Saline Controlled Study • Category: Sports Medicine | ||||||
| 07/16/2019 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $1,000.00 | Research |
| Study: nStride Saline Controlled Study • Category: Sports Medicine | ||||||
| 05/16/2019 | Pacira CryoTech Incorporated | IOVERA SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/18/2019 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $500.00 | Research |
| Study: Nstride Saline Controlled Study • Category: Sports Medicine | ||||||
| 04/09/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $31,796.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/09/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $4,084.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/29/2019 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $250.00 | Research |
| Study: Nstride Saline Controlled Study • Category: Sports Medicine | ||||||
| 01/24/2019 | Zimmer Biomet Holdings, Inc. | Nstride (Device) | — | Cash or cash equivalent | $875.00 | Research |
| Study: Nstride Saline Controlled Study • Category: Sports Medicine | ||||||
| 12/13/2018 | Myoscience Inc. | — | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| 12/04/2018 | Smith & Nephew, Inc. | — | Travel and Lodging | Cash or cash equivalent | $384.90 | General |
| 12/04/2018 | Smith & Nephew, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| 12/04/2018 | Smith & Nephew, Inc. | — | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| 11/01/2018 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 08/21/2018 | Smith & Nephew, Inc. | Navio Surgical System (Device), Fast-Fix 360, Coblation Wands | Food and Beverage | In-kind items and services | $79.70 | General |
| Category: Recon Robotics | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| nStride Saline Controlled Study | Zimmer Biomet Holdings, Inc. | $7,250 | 5 |
| Nstride Saline Controlled Study | Zimmer Biomet Holdings, Inc. | $2,125 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 4,360 | 16,687 | $1.6M | $387,652 |
| 2022 | 41 | 4,466 | 16,590 | $1.6M | $404,490 |
| 2021 | 37 | 3,741 | 15,264 | $1.3M | $354,167 |
| 2020 | 34 | 2,998 | 13,550 | $1.0M | $258,131 |
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 577 | 3,259 | $221,612 | $55,716 | 25.1% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 133 | 564 | $275,232 | $54,372 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 398 | 648 | $134,784 | $53,716 | 39.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 335 | 888 | $184,704 | $43,211 | 23.4% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 295 | 1,117 | $87,126 | $27,995 | 32.1% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 360 | 1,624 | $126,672 | $24,727 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 201 | 201 | $65,928 | $18,649 | 28.3% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 273 | 793 | $53,924 | $16,296 | 30.2% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2023 | 29 | 2,227 | $71,264 | $16,138 | 22.6% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 271 | 397 | $54,786 | $12,201 | 22.3% |
| 97161 | Evaluation for physical therapy, typically 20 minutes | Office | 2023 | 166 | 174 | $41,412 | $11,776 | 28.4% |
| 97535 | Training for self-care or home management, each 15 minutes | Office | 2023 | 181 | 314 | $21,352 | $6,450 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 98 | $13,524 | $6,124 | 45.3% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2023 | 83 | 83 | $19,754 | $5,756 | 29.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 155 | 201 | $27,738 | $4,580 | 16.5% |
| 73221 | Mri scan of arm joint without contrast | Office | 2023 | 27 | 28 | $41,664 | $3,960 | 9.5% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 24 | 25 | $37,200 | $3,683 | 9.9% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 26 | 26 | $54,288 | $3,491 | 6.4% |
| 97116 | Therapy procedure for walking training, each 15 minutes | Office | 2023 | 106 | 215 | $14,620 | $3,445 | 23.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 241 | 3,151 | $15,062 | $2,502 | 16.6% |
| 97113 | Therapy procedure using water pool to exercises, each 15 minutes | Office | 2023 | 16 | 81 | $6,318 | $1,871 | 29.6% |
| 97163 | Evaluation for physical therapy, typically 45 minutes | Office | 2023 | 22 | 22 | $5,236 | $1,305 | 24.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 50 | 51 | $6,528 | $1,248 | 19.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 34 | 51 | $6,528 | $1,188 | 18.2% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 38 | 38 | $5,244 | $949.90 | 18.1% |
About Frederick Azar
Frederick Azar is a Sports Medicine healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821084633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frederick Azar has received a total of $71,214 in payments from pharmaceutical and medical device companies, with $415.12 received in 2024. These payments were reported across 41 transactions from 9 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($52,713).
As a Medicare-enrolled provider, Azar has provided services to 15,565 Medicare beneficiaries, totaling 62,091 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Sports Medicine
- Location Germantown, TN
- Active Since 09/27/2005
- Last Updated 01/25/2023
- Taxonomy Code 207XX0005X
- Entity Type Individual
- NPI Number 1821084633
Products in Payments
- EXPAREL (Drug) $35,881
- IOVERA SYSTEM (Device) $11,716
- Nstride (Device) $9,415
- Iovera System (Device) $5,866
- Navio Surgical System (Device) $706.89
- Q-FIX (Device) $304.41
- CLARIX (Medical Supply) $110.71
- MACI (Biological) $25.77
- Kerecis Omega3 SurgiClose (Device) $21.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Germantown
Austin Hardaway, Md, MD
Sports Medicine — Payments: $29,570
Dr. James Dove, Md, MD
Sports Medicine — Payments: $23,312
Barry Phillips, M.d, M.D
Sports Medicine — Payments: $6,054
Matthew Gilbert, Md, MD
Sports Medicine — Payments: $282.88
John Hyden, Md, MD
Sports Medicine — Payments: $247.00
Dr. Joshua Brandon, Md, MD
Sports Medicine — Payments: $44.26